1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9620):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-139938S
    (±)11(12)-EET methyl ester-d11
    (±)11(12)-EET-d11 methyl ester is the deuterium labeled (±)11(12)-EET methyl ester.
    (±)11(12)-EET methyl ester-d<sub>11</sub>
  • HY-150716S
    Iodopropamine-d3
    Iodopropamine-d3 is the deuterium labeled Iodopropamine.
    Iodopropamine-d<sub>3</sub>
  • HY-W342261S
    1,2,3,5-Tetramethylbenzene-d14
    1,2,3,5-Tetramethylbenzene-d14 is the deuterium labeled 1,2,3,5-Tetramethylbenzene.
    1,2,3,5-Tetramethylbenzene-d<sub>14</sub>
  • HY-W778300
    Sodium 2-cyanoacetate-13C2
    Sodium 2-cyanoacetate-13C2 (Sodium cyanoacetate-13C2) is the 13C-labeled Sodium 2-cyanoacetate (HY-W129503).
    Sodium 2-cyanoacetate-<sup>13</sup>C<sub>2</sub>
  • HY-B0380S1
    Trimebutine-d5 fumarate
    Trimebutine-d5 fumarate is deuterium labeled Trimebutine fumarate. Trimebutine fumarate is a multi-target inhibitor and opioid receptor agonist with antimuscarinic activity. Trimebutine fumarate inhibits L-type Ca2+ channels and large-conductance calcium-activated potassium channels (BKCa channels), thereby inhibiting extracellular calcium influx and potassium ion efflux. Trimebutine fumarate also targets Toll-like receptors, inhibits Toll-like receptor 2/4/7/8/9 signals, and inhibits LPS-induced IRAK1 activation, as well as ERK1/2, JNK and NF-κB activation, thereby exerting anti-inflammatory effects. Trimebutine fumarate also induces tumor cell apoptosis by inhibiting the AKT/ERK pathway. Trimebutine fumarate also inhibits excessive contraction of smooth muscle and can be used in the study of gastrointestinal disorders such as irritable bowel syndrome (IBS).
    Trimebutine-d<sub>5</sub> fumarate
  • HY-Y0503S
    Methyltriphenylphosphonium iodide-d3
    Methyltriphenylphosphonium iodide-d3 is the deuterium labeled Methyltriphenylphosphonium iodide.
    Methyltriphenylphosphonium iodide-d<sub>3</sub>
  • HY-100659S
    Dihydrodiol-Ibrutinib-d5
    Dihydrodiol-Ibrutinib-d5 is the deuterium labeled Dihydrodiol-Ibrutinib (HY-100659). Dihydrodiol-Ibrutinib is a dihydrodiol active metabolite of Ibrutinib (HY-10997), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib.
    Dihydrodiol-Ibrutinib-d<sub>5</sub>
  • HY-139474S1
    N-Acetyl-S-(carbamoylethyl)-L-cysteine-d4
    N-Acetyl-S-(carbamoylethyl)-L-cysteine-d4 is the deuterium labeled N-Acetyl-S-(carbamoylethyl)-L-cysteine.
    N-Acetyl-S-(carbamoylethyl)-L-cysteine-d<sub>4</sub>
  • HY-W706160
    Di-p-tolyl Phosphorochloridate-d14
    Di-p-tolyl Phosphorochloridate-d14 is the deuterium labeled Di-p-tolyl phosphorochloridate (HY-W706159).
    Di-p-tolyl Phosphorochloridate-d<sub>14</sub>
  • HY-151909S
    Endothall-3,4,4,5,5,6 H2O-d6
    Endothall-3,4,4,5,5,6 H2O-d6 is the deuterium labeled 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid hydrate (HY-W714211).
    Endothall-3,4,4,5,5,6 H2O-d<sub>6</sub>
  • HY-15731S1
    Estetrol-d4 (Major)
    Estetrol-d4 (Major) is the deuterium labeled Estetrol (HY-15731). Estetrol, an orally active estrogen synthesized exclusively during pregnancy by the human fetal liver, is a selective nuclear estrogen receptor modulator. Estetrol binds ERα as well as ERβ (with a fourfold lower affinity). Estetrol increases eNOS expression/activity and NO synthesis in endothelial cells. Estetrol exerts estrogenic actions on the endometrium or the central nervous system but presents antagonistic effects on the breast. Estetrol can be used in contraception and menopausal hormone research.
    Estetrol-d<sub>4</sub> (Major)
  • HY-143797S
    Almotriptan-d6 maleate
    Almotriptan-d6 (maleate) is the deuterium labeled Almotriptan maleate.
    Almotriptan-d<sub>6</sub> maleate
  • HY-152048S
    Methomyl-d3
    Methomyl-d3 is a deuterium labeled compound.
    Methomyl-d<sub>3</sub>
  • HY-146868S
    1-Heptadecanoyl-2-oleoyl-sn-glycero-3-phospho- L-serine-d5 sodium
    1-Heptadecanoyl-2-oleoyl-sn-glycero-3-phospho- L-serine-d5 (sodium) is deuterium labeled 1-Heptadecanoyl-2-oleoyl-sn-glycero-3-phospho- L-serine (sodium).
    1-Heptadecanoyl-2-oleoyl-sn-glycero-3-phospho- L-serine-d<sub>5</sub> sodium
  • HY-W770914
    Stearoyl-L-carnitine chloride-13C3
    Stearoyl-L-carnitine chloride-13C3 is the 13C-labeled Stearoyl-L-carnitine chloride (HY-130466). Stearoyl-L-carnitine chloride is an endogenous long-chain acylcarnitine. Stearoyl-L-carnitine chloride is a less potent inhibitor of GlyT2. Stearoyl-L-carnitine chloride inhibits glycine responses by 16.8% at concentrations up 3 μM.
    Stearoyl-L-carnitine chloride-<sup>13</sup>C<sub>3</sub>
  • HY-W099570S
    Stearate-d35 sodium
    Stearate-d35 (sodium) is the deuterium labeled Stearate.
    Stearate-d<sub>35</sub> sodium
  • HY-W779236
    Ethyl Propargylate-13C3
    Ethyl Propargylate-13C3 (Propiolic acid ethyl ester-13C3) is the 13C-labeled Ethyl propiolate (HY-Y0871).
    Ethyl Propargylate-<sup>13</sup>C<sub>3</sub>
  • HY-144193S
    MCPP methyl ester-d3
    MCPP methyl ester-d3 is the deuterium labeled MCPP methyl ester.
    MCPP methyl ester-d<sub>3</sub>
  • HY-132947S
    Heptadecanoyl-L-carnitine-d3 chloride
    Heptadecanoyl-L-carnitine-d3 (chloride) is the deuterium labeled Heptadecanoyl-L-carnitine chloride.
    Heptadecanoyl-L-carnitine-d<sub>3</sub> chloride
  • HY-13011S
    Alectinib-d8
    Alectinib-d8 is the deuterium labeled Alectinib. Alectinib (CH5424802) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively. Alectinib demonstrates effective central nervous system (CNS) penetration.
    Alectinib-d<sub>8</sub>